Hungary's Richter, Palatin Technologies sign drug license deal
BUDAPEST, Sept 3 (Reuters) - Hungary's Richter and Palatin Technologies have signed a license agreement to co-develop and sell a drug called bremelanotide in the EU, other European countries and additional selected countries, the companies said on Wednesday.
